Objective Many vasodilator drugs, including inhaled iloprost, are used to treat insufficient pulmonary vasodilatation, which is the main issue in pulmonary hypertension in newborns
Persistent pulmonary hypertension of the newborn (PPHN) is the most common neonatal form and mostly ...
Endotracheal instillation of prostacyclin in preterm infants with persistent pulmonary hypertension ...
Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children wit...
Objective Many vasodilator drugs, including inhaled iloprost, are used to treat insufficient pulmona...
Pulmonary artery hypertension is a common cardiovascular complication in preterm infants with bronch...
ObjectiveThis study was performed to examine the effectiveness and safety of oral sildenafil and inh...
Respiratory failure in the premature newborn may be complicated by pulmonary hypertension (PAH) that...
Persistent pulmonary hypertension of the newborn (PPHN) is rare, but life-threatening. If not treate...
Inhaled nitric oxide (iNO) has an established role in the treatment of pulmonary hypertension in the...
Inhaled iloprost is attracting growing interest as a potential alternative and/or adjuvant to inhale...
Inhaled nitric oxide (iNO) has been used to assess the vasodilator capacity of the pulmonary vascula...
Abstract Background Inhaled nitric oxide (iNO) has been approved for the treatment of persistent pul...
Cecile Tissot, Maurice BeghettiPediatric Cardiology Unit, Department of the Child and Adolescent, Un...
Objective: To determine the efficacy and safety of endotracheal instillation of iloprost as a rescue...
Nathan Cosa,1 Edward Costa Jr2 1Department of Respiratory Care, Banner Desert Medical Center, Cardon...
Persistent pulmonary hypertension of the newborn (PPHN) is the most common neonatal form and mostly ...
Endotracheal instillation of prostacyclin in preterm infants with persistent pulmonary hypertension ...
Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children wit...
Objective Many vasodilator drugs, including inhaled iloprost, are used to treat insufficient pulmona...
Pulmonary artery hypertension is a common cardiovascular complication in preterm infants with bronch...
ObjectiveThis study was performed to examine the effectiveness and safety of oral sildenafil and inh...
Respiratory failure in the premature newborn may be complicated by pulmonary hypertension (PAH) that...
Persistent pulmonary hypertension of the newborn (PPHN) is rare, but life-threatening. If not treate...
Inhaled nitric oxide (iNO) has an established role in the treatment of pulmonary hypertension in the...
Inhaled iloprost is attracting growing interest as a potential alternative and/or adjuvant to inhale...
Inhaled nitric oxide (iNO) has been used to assess the vasodilator capacity of the pulmonary vascula...
Abstract Background Inhaled nitric oxide (iNO) has been approved for the treatment of persistent pul...
Cecile Tissot, Maurice BeghettiPediatric Cardiology Unit, Department of the Child and Adolescent, Un...
Objective: To determine the efficacy and safety of endotracheal instillation of iloprost as a rescue...
Nathan Cosa,1 Edward Costa Jr2 1Department of Respiratory Care, Banner Desert Medical Center, Cardon...
Persistent pulmonary hypertension of the newborn (PPHN) is the most common neonatal form and mostly ...
Endotracheal instillation of prostacyclin in preterm infants with persistent pulmonary hypertension ...
Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children wit...
DOI
Add to ORKG